Business
Why the Dimerix (ASX:DXB) share price is surging 6% higher today
The Dimerix Ltd (ASX: DXB) share price lifted higher today after the company announced the start of its second clinical study on lead drug candidate, DMX-200. At the time of writing, the Dimerix share price is up 6.1% at 26 cents.
What’s driving the Dimerix share price?
The Dimerix share price is storming higher following the announcement of its international study into COVID-19 patients. Led by Professor Meg Jardine at the University of Sydney Australia, the clinical trial will collaborate with Professor Vivek Jha and The George Institute for Global Health, in India.
DMX-200 was chosen for a partner study of the controlled evaluation of angiotensin receptor blockers for COVID-19 respiratory disease (Clarity) study. The Clarity…
-
Noosa News21 hours agoInvestigations underway after dead body found on Townsville road
-
Noosa News24 hours agoThe Diageo World Class Finals Will See the Country’s Eight Best Bartenders Shaking and Stirring for Their Chance to Represent Australia on the Global Stage
-
General14 hours agoChris Brown pleads not guilty over alleged London nightclub beating
-
General14 hours agoOil tumbles, stocks rebound after Trump Mideast pause